98 related articles for article (PubMed ID: 24881814)
1. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O
Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.
Treeck O; Elemenler E; Kriener C; Horn F; Springwald A; Hartmann A; Ortmann O
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):207-11. PubMed ID: 19429453
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.
Fischer C; Juhasz-Boess I; Lattrich C; Ortmann O; Treeck O
Gynecol Endocrinol; 2010 Jan; 26(1):4-9. PubMed ID: 19639498
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer.
Lattrich C; Häring J; Schüler S; Skrzypczak M; Ortmann O; Treeck O
Arch Gynecol Obstet; 2014 Mar; 289(3):631-5. PubMed ID: 23974281
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the epidemiological and prognosis significance of ESR2 rs3020450 polymorphism in ovarian cancer.
Feng Y; Peng Z; Liu W; Yang Z; Shang J; Cui L; Duan F
Gene; 2019 Aug; 710():316-323. PubMed ID: 31200086
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Causes Control; 2009 Feb; 20(1):47-55. PubMed ID: 18704709
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta (ESR2 ) polymorphisms and endometrial cancer (United States).
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Causes Control; 2004 Aug; 15(6):627-33. PubMed ID: 15280642
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
Pirskanen M; Hiltunen M; Mannermaa A; Helisalmi S; Lehtovirta M; Hänninen T; Soininen H
Eur J Hum Genet; 2005 Sep; 13(9):1000-6. PubMed ID: 15944651
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
13. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.
Goumidi L; Dahlman-Wright K; Tapia-Paez I; Matsson H; Pasquier F; Amouyel P; Kere J; Lambert JC; Meirhaeghe A
J Alzheimers Dis; 2011; 26(3):431-9. PubMed ID: 21673408
[TBL] [Abstract][Full Text] [Related]
14. Significance of rs1271572 in the estrogen receptor beta gene promoter and its correlation with breast cancer in a southwestern Chinese population.
Chen L; Liang Y; Qiu J; Zhang L; Chen X; Luo X; Jiang J
J Biomed Sci; 2013 May; 20(1):32. PubMed ID: 23711151
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
16. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
19. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
20. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]